Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

598.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 682.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.50m
  • Volume: 48,787
  • Market Cap: £720.57m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica acquires US viral vector facility

By Iain Gilbert

Date: Tuesday 07 Oct 2025

(Sharecast News) - Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site in Rockville, Maryland, from ABL for $60m in cash, expanding its US footprint and strengthening its contract development and manufacturing offering.

Oxford Biomedica reiterates outlook as interim losses narrow

By Abigail Townsend

Date: Tuesday 23 Sep 2025

(Sharecast News) - Oxford Biomedica reiterated full-year guidance on Tuesday, after the biopharma saw strong demand throughout the first half and trimmed losses.

RBC Capital Markets raises target price on OXB

By Iain Gilbert

Date: Tuesday 26 Aug 2025

(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on gene and cell therapy firm OXB from 800p to 930p on Tuesday following its recent oversubscribed £60m equity funding and revenue guidance reiteration.

Oxford Biomedica raises £60m to bolster US capac... 15-Aug-2025 ShareCast
Oxford Biomedica agrees new four-year, $125m loa... 01-Aug-2025 ShareCast
Oxford Biomedica flags sharp rise in first-half ... 28-Jul-2025 ShareCast
Oxford Biomedica acquires last 10pc stake in US ... 23-Jun-2025 ShareCast
Oxford Biomedica reports first-half revenue growth 23-Sep-2024 ShareCast
Oxford Biomedica still expecting small loss afte... 08-Aug-2024 ShareCast
Oxford Biomedica appoints new finance chief 17-Jul-2024 ShareCast
Oxford Biomedica confident as it moves away from... 29-Apr-2024 ShareCast
Oxford Biomedica shares rise on post-acquisition... 05-Mar-2024 ShareCast
Director dealings: TUI, Oxford Biomedica board m... 27-Sep-2023 ShareCast
Liberum cuts target price for Oxford Biomedica, ... 28-Nov-2022 ShareCast
Oxford Biomedica taps Frank Mathias as its new CEO 22-Nov-2022 ShareCast
Oxford Biomedica swings to loss as Covid vaccine... 15-Sep-2022 ShareCast
Oxford Biomedica inks LSA with new US biotech pa... 07-Sep-2022 ShareCast
Oxford Biomedica inks LSA with US biotech firm, ... 26-Jul-2022 ShareCast
Oxford Biomedica signs new Covid vaccine deal wi... 01-Jul-2022 ShareCast
Oxford Biomedica sees FDA lift clinical hold on ... 14-Jun-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 598.00p
Change Today 4.00p
% Change 0.67 %
52 Week High 682.00p
52 Week Low 232.50p
Volume 48,787
Shares Issued 120.50m
Market Cap £720.57m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 20-Nov-2025

Time Volume / Share Price
14:35 1 @ 598.00p
14:35 23 @ 598.00p
14:34 1 @ 598.00p
14:33 1 @ 598.00p
14:33 1 @ 598.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page